Feasibility, validity and reliability of the Welsh EQ-5D health status questionnaire
Research output: Contribution to conference › Paper
Standard Standard
Feasibility, validity and reliability of the Welsh EQ-5D health status questionnaire. / Hughes, D.; Hughes, D.A.
2007. Paper presented at 12th Annual International Society for Pharmacoeconomics and Outcomes Research, Arlington, Virginia, USA.
2007. Paper presented at 12th Annual International Society for Pharmacoeconomics and Outcomes Research, Arlington, Virginia, USA.
Research output: Contribution to conference › Paper
HarvardHarvard
Hughes, D & Hughes, DA 2007, 'Feasibility, validity and reliability of the Welsh EQ-5D health status questionnaire', Paper presented at 12th Annual International Society for Pharmacoeconomics and Outcomes Research, Arlington, Virginia, USA, 3/01/02.
APA
Hughes, D., & Hughes, D. A. (2007). Feasibility, validity and reliability of the Welsh EQ-5D health status questionnaire. Paper presented at 12th Annual International Society for Pharmacoeconomics and Outcomes Research, Arlington, Virginia, USA.
CBE
Hughes D, Hughes DA. 2007. Feasibility, validity and reliability of the Welsh EQ-5D health status questionnaire. Paper presented at 12th Annual International Society for Pharmacoeconomics and Outcomes Research, Arlington, Virginia, USA.
MLA
Hughes, D. and D.A. Hughes Feasibility, validity and reliability of the Welsh EQ-5D health status questionnaire. 12th Annual International Society for Pharmacoeconomics and Outcomes Research, Arlington, Virginia, USA, 03 Jan 0002, Paper, 2007.
VancouverVancouver
Hughes D, Hughes DA. Feasibility, validity and reliability of the Welsh EQ-5D health status questionnaire. 2007. Paper presented at 12th Annual International Society for Pharmacoeconomics and Outcomes Research, Arlington, Virginia, USA.
Author
RIS
TY - CONF
T1 - Feasibility, validity and reliability of the Welsh EQ-5D health status questionnaire
AU - Hughes, D.
AU - Hughes, D.A.
PY - 2007/5/1
Y1 - 2007/5/1
M3 - Paper
T2 - 12th Annual International Society for Pharmacoeconomics and Outcomes Research, Arlington, Virginia, USA
Y2 - 3 January 0002
ER -